Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Chengcheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-7578-6152; OpenAlex author ID A5100389614. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Cell-in-Cell-Mediated Entosis Reveals a Progressive Mechanism in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2023.08.035↗
  2. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer. Co-author DOI 10.1186/s12885-022-09927-0↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianlu Song · 2 shared papers, 2022–2023 · strength 0.35
  2. Rexiati Ruze · 2 shared papers, 2022–2023 · strength 0.35
  3. Yuan Chen · 2 shared papers, 2022–2023 · strength 0.35
  4. Ruiyuan Xu · 2 shared papers, 2022–2023 · strength 0.35
  5. Xinpeng Yin · 2 shared papers, 2022–2023 · strength 0.35
  6. Yupei Zhao · 2 shared papers, 2022–2023 · strength 0.35
  7. Hui Zhang · 1 shared paper, 2023 · strength 0.18
  8. Qiang Xu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.